Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
TKPHF
TKPHF News & Events
-
Add to Watchlist
Trade TKPHF
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
TKPHF News
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
Takeda's Phase 3 Trial of Oral Zasocitinib for Plaque Psoriasis Meets Primary Objectives
Dec 18 2025
NASDAQ.COM
Takeda Canada: FRUZAQLA Now Covered by British Columbia Reimbursement
Dec 16 2025
NASDAQ.COM
Protagonist and Takeda Present 52-Week Rusfertide Data for Polycythemia Vera
Dec 06 2025
NASDAQ.COM
Ascentage Pharma Initiates Global Phase III Trial of Olverembatinib for Ph+ ALL
Dec 05 2025
NASDAQ.COM
Innovent and Takeda Finalize $11.4 Billion Partnership to Develop Next-Generation IO and ADC Treatments
Dec 05 2025
NASDAQ.COM
Takeda Reports Encouraging Interim Findings for Mezagitamab in IgA Nephropathy
Nov 08 2025
NASDAQ.COM
Takeda Pharmaceutical Q2 2025 Earnings Call Scheduled for 6:00 AM ET
Oct 30 2025
NASDAQ.COM
Show More News
TKPHF Events
No data
TKPHF Monitor News
No data
TKPHF Earnings Analysis
No Data
People Also Watch
